SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000812796-09-000022
Filing Date
2009-04-02
Accepted
2009-04-02 16:47:21
Documents
3
Period of Report
2009-04-02

Document Format Files

Seq Description Document Type Size
1 PRE 14A PROXY pre14aproxy.htm PRE 14A 312649
2 DOR LOGO doritslogo.jpg GRAPHIC 7451
3 5 YEAR MARKET GRAPH graphmarket5.jpg GRAPHIC 77454
  Complete submission text file 0000812796-09-000022.txt   431547
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-452-0001
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-16929 | Film No.: 09728270
SIC: 2834 Pharmaceutical Preparations